How AI Can Reduce Inspection Risk and Strengthen QMSR Readiness

The shift from QSR to QMSR represents a major regulatory change for medical device organizations. In 2026, the FDA is no longer focused solely on a trail of paperwork; it is evaluating whether companies can demonstrate a living, breathing, risk-integrated system. This shift moves the industry from documentation-based compliance to a model where ISO 14971 risk management must be woven into every thread of the organization. This webinar explores how organizations can respond to that shift by moving from reactive quality practices to a more proactive, integrated approach.

The challenge is that most legacy systems were not designed for this level of integration. When risk data lives in a vacuum, the QMS becomes a liability during an inspection. Under the new QMSR framework, investigators are prioritizing systemic effectiveness across connected quality processes. If change controls, CAPAs and supplier audits operate in silos rather than as part of an integrated quality system, organizations may be more vulnerable during inspections.

Rather than focusing on isolated corrective actions after issues arise, a proactive approach to QMSR readiness emphasizes cross-functional alignment, integrated risk management and stronger traceability across the QMS lifecycle. The webinar will also touch on how AI and digital tools can support visibility, traceability and more informed decision-making within a proactive quality framework. Attendees will learn how to align QMS practices with evolving FDA expectations and support a more consistent approach to compliance.